LEADER 01933nam  2200541 a 450 
001 9910643962103321
005 20230213211658.0
010   $a1-280-76831-2
010   $a9786613679086
010   $a0-470-71876-5
010   $a0-470-71613-4
035   $a(CKB)1000000000687628
035   $a(EBL)703723
035   $a(OCoLC)775867033
035   $a(SSID)ssj0000715088
035   $a(PQKBManifestationID)11377546
035   $a(PQKBTitleCode)TC0000715088
035   $a(PQKBWorkID)10701236
035   $a(PQKB)10090050
035   $a(MiAaPQ)EBC703723
035   $a(EXLCZ)991000000000687628
100   $a20120305d1951      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 12$aA Ciba Foundation symposium$b[electronic resource] $eliver disease /$fconsulting editor, Sheila Sherlock ; editor for the Ciba Foundation, G.E.W. Wolstenholme
210   $aLondon $cJ. & A. Churchill Ltd.$d1951
215   $a1 online resource (298 p.)
225 1 $aNovartis Foundation Symposia ;$vv.823
300   $a"With 112 illustrations."
311   $a0-470-72219-3 
320   $aIncludes bibliographical references and index.
327   $apt. 1. Protein metabolism in liver disease -- pt. 2. The ætiology of hepatic cirrhosis -- pt. 3. Ætiology of portal hypertension and ascites, and its treatment -- pt. 4. Pigment metabolism -- pt. 5. Splanching blood flow -- pt. 6. Infectious aspects of liver disease.
410  0$aNovartis Foundation Symposia
606   $aLiver$xDiseases
615  0$aLiver$xDiseases.
676   $a616.3/62
701   $aSherlock$b Sheila$cDame.$0101649
701   $aWolstenholme$b G. E. W$g(Gordon Ethelbert Ward)$063039
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910643962103321
996   $aA Ciba Foundation symposium$93005128
997   $aUNINA